ChemicalBook > CAS DataBase List > GLPG-1690
GLPG-1690
GLPG-1690
- CAS No.1628260-79-6
- Chemical Name:GLPG-1690
- CBNumber:CB93152899
- Molecular Formula:C30H33FN8O2S
- Formula Weight:588.7
- MOL File:1628260-79-6.mol
GLPG-1690 Property
- Density 1.42±0.1 g/cm3(Predicted)
- storage temp. Store at -20°C
- solubility DMSO:70.84(Max Conc. mg/mL);120.32(Max Conc. mM)
Ethanol:4.0(Max Conc. mg/mL);6.79(Max Conc. mM) - form A crystalline solid
- pka 13.72±0.20(Predicted)
- color White to off-white
- FDA UNII I02418V13W
Safety
-
Symbol(GHS)
- Signal wordWarning
- Hazard statements H302-H315-H319-H335
- Precautionary statements P261-P305+P351+P338
GLPG-1690 Chemical Properties,Usage,Production
- Uses GLPG1690 is a selective autotaxin inhibitor discovered by Galapagos, with potential application in idiopathic pulmonary disease (IPF). In a Phase 1 study in healthy human volunteers, GLPG1690 demonstrated favorable safety and tolerability, as well as a strong pharmacodynamic signal implying target engagement.
-
in vivo
Ziritaxestat (GLPG1690) inhibits ATX-induced LPA 18:2 production in mouse, rat, and healthy donor plasma in a concentration-dependent manner, with IC50 values of 418 nM, 542 nM, and 242 nM, respectively.Ziritaxestat (GLPG1690) displays improved pharmacokinetic properties, with a low plasma clearance and high bioavailability in mouse and rat. The good pharmacokinetic profile is further confirmed in dog, with Ziritaxestat (GLPG1690) showing low plasma clearance (0.12 L/h/kg) and a high bioavailability (63%)[1].
- IC 50 Autotaxin: 131 nM (IC50); Autotaxin: 15 nM (Ki)
GLPG-1690 Preparation Products And Raw materials
Raw materials
Preparation Products
Global(100)Suppliers
-
Supplier:
- Tel:+undefined-21-51877795
- Email:ivan@atkchemical.com
- Country:China
- ProdList:33024
- Advantage:60
-
Supplier:
- Tel:+1-631-485-4226
- Email:inquiry@bocsci.com
- Country:United States
- ProdList:19552
- Advantage:58
-
Supplier:
- Tel: +8618523575427
- Email:sales@conier.com
- Country:China
- ProdList:49732
- Advantage:58
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32159
- Advantage:58
-
Supplier:
- Tel:86-571-88216897,88216896<br/>13588875226
- Email:sales@hzclap.com
- Country:CHINA
- ProdList:6312
- Advantage:58
-
Supplier:
- Tel:+86-29-89586680<br/>+86-15129568250
- Email:1026@dideu.com
- Country:China
- ProdList:22854
- Advantage:58
-
Supplier:
- Tel:+1-2135480471<br/>+1-2135480471
- Email:sales@sarms4muscle.com
- Country:China
- ProdList:10473
- Advantage:58
-
Supplier:
- Tel:+1-708-310-1919<br/>+1-13798911105
- Email:sales@invivochem.cn
- Country:United States
- ProdList:6391
- Advantage:58
-
Supplier:
- Tel:+86-852-30606658
- Email:market18@leapchem.com
- Country:China
- ProdList:24727
- Advantage:58
-
Supplier:
- Tel:
- Email:support@targetmol.com
- Country:United States
- ProdList:38630
- Advantage:58
1628260-79-6, GLPG-1690Related Search:
- API
- APIS
- 化学试剂
- 高纯试剂
- 合成有机化合物配体
- 抑制剂
- C30H33FN8O2S
- 化合物GLPG1690,10 MM DMSO 溶液
- 2-[[2-乙基-6-[4-[2-(3-羟基-1-氮杂环丁基)-2-氧代乙基]-1-哌嗪基]-8-甲基咪唑并[1,2-A]吡啶-3-基](甲基)氨基]-4-(4-氟苯基)噻唑-5-甲腈
- 2-[(2-乙基-6-{4- [2-(3-羟基氮杂环丁烷-1-基)-2-氧代乙基]哌嗪-1-基}-8-甲基咪唑并[1,2-A]-吡啶)(甲基)氨基]-4-(4-氟苯基)-1,3-噻唑-5-甲腈
- 2-((2-乙基-6-(4-(2-(3-羟基氮杂环丁烷-1-基)-2-氧代乙基)哌嗪-1-基)-8-甲基咪唑并[1,2-A]吡啶-3-基)(甲基)氨基)-4-(4-氟苯基)噻唑-5-甲腈
- GLPG1690游离态(GLPG-1690)
- 2-[[2-乙基-6-[4-[2-(3-羟基-1-氮杂环丁烷基)-2-氧代乙基]-1-哌嗪基]-8-甲基咪唑并[1,2-A]吡啶-3-基]甲基氨基]-4-(4-氟苯基)-5-噻唑甲腈
- 化合物GLPG1690
- GLPG1690游离态
- 1628260-79-6
- Ziritaxestat, 10 mM in DMSO
- 2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-5-thiazolecarbonitrile
- 2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile
- Ziritaxestat (GLPG-1690)
- GLPG11690
- ziritaxestat
- 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile
- GLPG-1690 USP/EP/BP
- GLPG-1690; GLPG 1690; GLPG1690; ZIRITAXESTAT.
- GLPG 1690;GLPG1690
- CS-2644
- 5-Thiazolecarbonitrile, 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-
- GLPG-1690